nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Methotrexate—muscle cancer	0.271	0.491	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—muscle cancer	0.165	0.3	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—muscle cancer	0.115	0.209	CbGbCtD
Ganciclovir—Discomfort—Etoposide—muscle cancer	0.000588	0.00131	CcSEcCtD
Ganciclovir—Face oedema—Doxorubicin—muscle cancer	0.000581	0.0013	CcSEcCtD
Ganciclovir—Hypersensitivity—Dactinomycin—muscle cancer	0.000581	0.00129	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Vincristine—muscle cancer	0.000576	0.00128	CcSEcCtD
Ganciclovir—Confusional state—Etoposide—muscle cancer	0.000575	0.00128	CcSEcCtD
Ganciclovir—Cardiac arrest—Doxorubicin—muscle cancer	0.000572	0.00128	CcSEcCtD
Ganciclovir—Pancytopenia—Methotrexate—muscle cancer	0.000571	0.00127	CcSEcCtD
Ganciclovir—Anaphylactic shock—Etoposide—muscle cancer	0.000571	0.00127	CcSEcCtD
Ganciclovir—Mood swings—Doxorubicin—muscle cancer	0.00057	0.00127	CcSEcCtD
Ganciclovir—Infection—Etoposide—muscle cancer	0.000567	0.00126	CcSEcCtD
Ganciclovir—Ataxia—Doxorubicin—muscle cancer	0.000566	0.00126	CcSEcCtD
Ganciclovir—Asthenia—Dactinomycin—muscle cancer	0.000566	0.00126	CcSEcCtD
Ganciclovir—Blood creatinine increased—Doxorubicin—muscle cancer	0.000564	0.00126	CcSEcCtD
Ganciclovir—Dysuria—Methotrexate—muscle cancer	0.000562	0.00125	CcSEcCtD
Ganciclovir—Neutropenia—Methotrexate—muscle cancer	0.000562	0.00125	CcSEcCtD
Ganciclovir—Dehydration—Doxorubicin—muscle cancer	0.00056	0.00125	CcSEcCtD
Ganciclovir—Thrombocytopenia—Etoposide—muscle cancer	0.000559	0.00124	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000558	0.00124	CcSEcCtD
Ganciclovir—Tachycardia—Etoposide—muscle cancer	0.000557	0.00124	CcSEcCtD
Ganciclovir—Abdominal pain—Vincristine—muscle cancer	0.000557	0.00124	CcSEcCtD
Ganciclovir—Body temperature increased—Vincristine—muscle cancer	0.000557	0.00124	CcSEcCtD
Ganciclovir—Liver function test abnormal—Doxorubicin—muscle cancer	0.000556	0.00124	CcSEcCtD
Ganciclovir—Skin disorder—Etoposide—muscle cancer	0.000554	0.00124	CcSEcCtD
Ganciclovir—Erectile dysfunction—Methotrexate—muscle cancer	0.000553	0.00123	CcSEcCtD
Ganciclovir—Dry skin—Doxorubicin—muscle cancer	0.000552	0.00123	CcSEcCtD
Ganciclovir—Hyperhidrosis—Etoposide—muscle cancer	0.000552	0.00123	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Methotrexate—muscle cancer	0.000549	0.00122	CcSEcCtD
Ganciclovir—Hypokalaemia—Doxorubicin—muscle cancer	0.000548	0.00122	CcSEcCtD
Ganciclovir—Anorexia—Etoposide—muscle cancer	0.000544	0.00121	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000542	0.00121	CcSEcCtD
Ganciclovir—Diarrhoea—Dactinomycin—muscle cancer	0.000539	0.0012	CcSEcCtD
Ganciclovir—Pneumonia—Methotrexate—muscle cancer	0.000539	0.0012	CcSEcCtD
Ganciclovir—Nasopharyngitis—Doxorubicin—muscle cancer	0.000538	0.0012	CcSEcCtD
Ganciclovir—Infestation NOS—Methotrexate—muscle cancer	0.000536	0.00119	CcSEcCtD
Ganciclovir—Infestation—Methotrexate—muscle cancer	0.000536	0.00119	CcSEcCtD
Ganciclovir—Hypotension—Etoposide—muscle cancer	0.000533	0.00119	CcSEcCtD
Ganciclovir—Gastritis—Doxorubicin—muscle cancer	0.000533	0.00119	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000531	0.00118	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000531	0.00118	CcSEcCtD
Ganciclovir—Muscular weakness—Doxorubicin—muscle cancer	0.000531	0.00118	CcSEcCtD
Ganciclovir—Renal failure—Methotrexate—muscle cancer	0.000527	0.00117	CcSEcCtD
Ganciclovir—Abdominal distension—Doxorubicin—muscle cancer	0.000524	0.00117	CcSEcCtD
Ganciclovir—Stomatitis—Methotrexate—muscle cancer	0.000522	0.00116	CcSEcCtD
Ganciclovir—Conjunctivitis—Methotrexate—muscle cancer	0.000521	0.00116	CcSEcCtD
Ganciclovir—Dysphagia—Doxorubicin—muscle cancer	0.00052	0.00116	CcSEcCtD
Ganciclovir—Hypersensitivity—Vincristine—muscle cancer	0.000519	0.00116	CcSEcCtD
Ganciclovir—Eosinophilia—Doxorubicin—muscle cancer	0.000515	0.00115	CcSEcCtD
Ganciclovir—Sweating—Methotrexate—muscle cancer	0.000514	0.00114	CcSEcCtD
Ganciclovir—Paraesthesia—Etoposide—muscle cancer	0.000512	0.00114	CcSEcCtD
Ganciclovir—Haematuria—Methotrexate—muscle cancer	0.000511	0.00114	CcSEcCtD
Ganciclovir—Pancreatitis—Doxorubicin—muscle cancer	0.00051	0.00114	CcSEcCtD
Ganciclovir—Dyspnoea—Etoposide—muscle cancer	0.000509	0.00113	CcSEcCtD
Ganciclovir—Somnolence—Etoposide—muscle cancer	0.000507	0.00113	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000507	0.00113	CcSEcCtD
Ganciclovir—Asthenia—Vincristine—muscle cancer	0.000505	0.00113	CcSEcCtD
Ganciclovir—Vomiting—Dactinomycin—muscle cancer	0.000501	0.00112	CcSEcCtD
Ganciclovir—Agranulocytosis—Methotrexate—muscle cancer	0.0005	0.00111	CcSEcCtD
Ganciclovir—Rash—Dactinomycin—muscle cancer	0.000497	0.00111	CcSEcCtD
Ganciclovir—Decreased appetite—Etoposide—muscle cancer	0.000496	0.00111	CcSEcCtD
Ganciclovir—Pancytopenia—Doxorubicin—muscle cancer	0.000494	0.0011	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Etoposide—muscle cancer	0.000493	0.0011	CcSEcCtD
Ganciclovir—Fatigue—Etoposide—muscle cancer	0.000492	0.0011	CcSEcCtD
Ganciclovir—Pain—Etoposide—muscle cancer	0.000488	0.00109	CcSEcCtD
Ganciclovir—Constipation—Etoposide—muscle cancer	0.000488	0.00109	CcSEcCtD
Ganciclovir—Neutropenia—Doxorubicin—muscle cancer	0.000487	0.00108	CcSEcCtD
Ganciclovir—Dysuria—Doxorubicin—muscle cancer	0.000487	0.00108	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000484	0.00108	CcSEcCtD
Ganciclovir—Haemoglobin—Methotrexate—muscle cancer	0.000483	0.00108	CcSEcCtD
Ganciclovir—Diarrhoea—Vincristine—muscle cancer	0.000482	0.00107	CcSEcCtD
Ganciclovir—Haemorrhage—Methotrexate—muscle cancer	0.000481	0.00107	CcSEcCtD
Ganciclovir—Hepatitis—Methotrexate—muscle cancer	0.000481	0.00107	CcSEcCtD
Ganciclovir—Pollakiuria—Doxorubicin—muscle cancer	0.000481	0.00107	CcSEcCtD
Ganciclovir—Pharyngitis—Methotrexate—muscle cancer	0.000477	0.00106	CcSEcCtD
Ganciclovir—Urinary tract disorder—Methotrexate—muscle cancer	0.000475	0.00106	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000475	0.00106	CcSEcCtD
Ganciclovir—Urethral disorder—Methotrexate—muscle cancer	0.000471	0.00105	CcSEcCtD
Ganciclovir—Weight decreased—Doxorubicin—muscle cancer	0.000471	0.00105	CcSEcCtD
Ganciclovir—Feeling abnormal—Etoposide—muscle cancer	0.00047	0.00105	CcSEcCtD
Ganciclovir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000469	0.00105	CcSEcCtD
Ganciclovir—Nausea—Dactinomycin—muscle cancer	0.000468	0.00104	CcSEcCtD
Ganciclovir—Pneumonia—Doxorubicin—muscle cancer	0.000467	0.00104	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Etoposide—muscle cancer	0.000467	0.00104	CcSEcCtD
Ganciclovir—Dizziness—Vincristine—muscle cancer	0.000466	0.00104	CcSEcCtD
Ganciclovir—Infestation—Doxorubicin—muscle cancer	0.000464	0.00103	CcSEcCtD
Ganciclovir—Infestation NOS—Doxorubicin—muscle cancer	0.000464	0.00103	CcSEcCtD
Ganciclovir—Visual impairment—Methotrexate—muscle cancer	0.000464	0.00103	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00046	0.00103	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—muscle cancer	0.000456	0.00102	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—muscle cancer	0.000455	0.00101	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000455	0.00101	CcSEcCtD
Ganciclovir—Urticaria—Etoposide—muscle cancer	0.000453	0.00101	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—muscle cancer	0.000452	0.00101	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—muscle cancer	0.000452	0.00101	CcSEcCtD
Ganciclovir—Abdominal pain—Etoposide—muscle cancer	0.000451	0.00101	CcSEcCtD
Ganciclovir—Body temperature increased—Etoposide—muscle cancer	0.000451	0.00101	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—muscle cancer	0.000451	0.00101	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—muscle cancer	0.000451	0.00101	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—muscle cancer	0.000448	0.000999	CcSEcCtD
Ganciclovir—Vomiting—Vincristine—muscle cancer	0.000448	0.000998	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—muscle cancer	0.000445	0.000991	CcSEcCtD
Ganciclovir—Rash—Vincristine—muscle cancer	0.000444	0.00099	CcSEcCtD
Ganciclovir—Dermatitis—Vincristine—muscle cancer	0.000444	0.000989	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—muscle cancer	0.000442	0.000986	CcSEcCtD
Ganciclovir—Headache—Vincristine—muscle cancer	0.000441	0.000983	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000439	0.000978	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—muscle cancer	0.000436	0.000973	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—muscle cancer	0.000433	0.000966	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—muscle cancer	0.000433	0.000965	CcSEcCtD
Ganciclovir—Chills—Methotrexate—muscle cancer	0.000432	0.000962	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—muscle cancer	0.000425	0.000947	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—muscle cancer	0.000421	0.000939	CcSEcCtD
Ganciclovir—Hypersensitivity—Etoposide—muscle cancer	0.00042	0.000937	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—muscle cancer	0.000419	0.000933	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—muscle cancer	0.000419	0.000933	CcSEcCtD
Ganciclovir—Nausea—Vincristine—muscle cancer	0.000418	0.000932	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—muscle cancer	0.000418	0.000931	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—muscle cancer	0.000416	0.000928	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—muscle cancer	0.000416	0.000928	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—muscle cancer	0.000414	0.000924	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—muscle cancer	0.000413	0.000921	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—muscle cancer	0.000411	0.000917	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—muscle cancer	0.00041	0.000914	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—muscle cancer	0.00041	0.000914	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—muscle cancer	0.000409	0.000912	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—muscle cancer	0.000409	0.000912	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—muscle cancer	0.000408	0.00091	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—muscle cancer	0.000405	0.000903	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—muscle cancer	0.000404	0.0009	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—muscle cancer	0.000401	0.000895	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—muscle cancer	0.000395	0.000879	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—muscle cancer	0.000394	0.000878	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—muscle cancer	0.00039	0.00087	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—muscle cancer	0.000388	0.000866	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—muscle cancer	0.000388	0.000865	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—muscle cancer	0.000387	0.000862	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—muscle cancer	0.000378	0.000842	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—muscle cancer	0.000378	0.000842	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—muscle cancer	0.000377	0.000841	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—muscle cancer	0.000376	0.000838	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—muscle cancer	0.000375	0.000837	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—muscle cancer	0.000375	0.000835	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—muscle cancer	0.000374	0.000833	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—muscle cancer	0.000372	0.000829	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—muscle cancer	0.000368	0.00082	CcSEcCtD
Ganciclovir—Cough—Methotrexate—muscle cancer	0.000365	0.000814	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—muscle cancer	0.000365	0.000813	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—muscle cancer	0.000363	0.000809	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—muscle cancer	0.000363	0.000808	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—muscle cancer	0.000363	0.000808	CcSEcCtD
Ganciclovir—Rash—Etoposide—muscle cancer	0.00036	0.000802	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—muscle cancer	0.000359	0.000801	CcSEcCtD
Ganciclovir—Headache—Etoposide—muscle cancer	0.000357	0.000797	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—muscle cancer	0.000357	0.000796	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—muscle cancer	0.000356	0.000794	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—muscle cancer	0.000356	0.000794	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—muscle cancer	0.000356	0.000794	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—muscle cancer	0.000356	0.000793	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—muscle cancer	0.000355	0.000791	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000354	0.000789	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—muscle cancer	0.000352	0.000785	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—muscle cancer	0.000352	0.000785	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—muscle cancer	0.000351	0.000782	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—muscle cancer	0.000349	0.000777	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—muscle cancer	0.000345	0.000768	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—muscle cancer	0.000342	0.000762	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—muscle cancer	0.000342	0.000762	CcSEcCtD
Ganciclovir—Infection—Methotrexate—muscle cancer	0.000339	0.000757	CcSEcCtD
Ganciclovir—Nausea—Etoposide—muscle cancer	0.000339	0.000755	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—muscle cancer	0.000336	0.00075	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—muscle cancer	0.000335	0.000747	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—muscle cancer	0.000335	0.000746	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—muscle cancer	0.000333	0.000743	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—muscle cancer	0.000332	0.00074	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—muscle cancer	0.00033	0.000736	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—muscle cancer	0.000327	0.000729	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—muscle cancer	0.000326	0.000726	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—muscle cancer	0.000326	0.000726	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—muscle cancer	0.000325	0.000723	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—muscle cancer	0.000319	0.000712	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—muscle cancer	0.000316	0.000705	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—muscle cancer	0.000314	0.0007	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—muscle cancer	0.000313	0.000698	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000311	0.000694	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—muscle cancer	0.000309	0.000689	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—muscle cancer	0.000309	0.000688	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—muscle cancer	0.000309	0.000688	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—muscle cancer	0.000309	0.000688	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—muscle cancer	0.000308	0.000686	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—muscle cancer	0.000307	0.000684	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000307	0.000683	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—muscle cancer	0.000305	0.00068	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—muscle cancer	0.000305	0.000679	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—muscle cancer	0.000304	0.000677	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—muscle cancer	0.000302	0.000673	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—muscle cancer	0.000301	0.00067	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—muscle cancer	0.000298	0.000665	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—muscle cancer	0.000297	0.000662	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—muscle cancer	0.000296	0.000659	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—muscle cancer	0.000296	0.000659	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000295	0.000658	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—muscle cancer	0.000295	0.000657	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—muscle cancer	0.000294	0.000655	CcSEcCtD
Ganciclovir—Pain—Methotrexate—muscle cancer	0.000292	0.000651	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—muscle cancer	0.00029	0.000646	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—muscle cancer	0.000289	0.000644	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—muscle cancer	0.000287	0.000641	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000286	0.000638	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—muscle cancer	0.000282	0.000629	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—muscle cancer	0.000282	0.000628	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000279	0.000623	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—muscle cancer	0.000276	0.000616	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—muscle cancer	0.000271	0.000605	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—muscle cancer	0.00027	0.000602	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—muscle cancer	0.00027	0.000602	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00027	0.000601	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—muscle cancer	0.000268	0.000596	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—muscle cancer	0.000266	0.000592	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—muscle cancer	0.000264	0.000588	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—muscle cancer	0.000263	0.000586	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—muscle cancer	0.00026	0.00058	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—muscle cancer	0.000257	0.000573	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000255	0.000569	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—muscle cancer	0.000255	0.000569	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—muscle cancer	0.000253	0.000564	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—muscle cancer	0.000253	0.000564	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—muscle cancer	0.000252	0.000561	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—muscle cancer	0.000245	0.000546	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—muscle cancer	0.000244	0.000543	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000242	0.000539	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—muscle cancer	0.000242	0.000539	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—muscle cancer	0.000235	0.000524	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—muscle cancer	0.000234	0.000521	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—muscle cancer	0.000234	0.000521	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—muscle cancer	0.000234	0.000521	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—muscle cancer	0.000226	0.000504	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—muscle cancer	0.000218	0.000486	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—muscle cancer	0.000217	0.000484	CcSEcCtD
Ganciclovir—Rash—Methotrexate—muscle cancer	0.000215	0.00048	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—muscle cancer	0.000215	0.00048	CcSEcCtD
Ganciclovir—Headache—Methotrexate—muscle cancer	0.000214	0.000477	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—muscle cancer	0.000212	0.000473	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—muscle cancer	0.000209	0.000467	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—muscle cancer	0.000203	0.000452	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—muscle cancer	0.000202	0.000451	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—muscle cancer	0.000196	0.000436	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—muscle cancer	0.000188	0.000419	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—muscle cancer	0.000187	0.000416	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—muscle cancer	0.000186	0.000415	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—muscle cancer	0.000185	0.000413	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—muscle cancer	0.000176	0.000392	CcSEcCtD
